Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome

被引:87
作者
Choi, K. M. [1 ]
Ryu, O. H. [1 ]
Lee, K. W. [1 ]
Kim, H. Y. [1 ]
Seo, J. A. [1 ]
Kim, S. G. [1 ]
Kim, N. H. [1 ]
Choi, D. S. [1 ]
Baik, S. H. [1 ]
机构
[1] Korea Univ, Guro Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul 152050, South Korea
关键词
C-reactive protein; interleukin-6; interleukin-10; adiponectin; metabolic syndrome;
D O I
10.1016/j.diabres.2006.06.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the association between interleukin-10 (IL-10), adiponectin levels and inflammatory markers such as interleukin-6 (IL-6) and high-sensitive C-reactive protein (hsCRP). Furthermore, the association of these anti-/pro-inflammatory cytokine levels with the metabolic syndrome was investigated. The study subjects were composed of 312 Korean individuals without diabetes. Serum adiponectin level was associated with hsCRP (r = -0.21, P < 0.001), IL-6 (r = -0. 13, P < 0.05) and IL-10 (r = -0.22, P < 0.001) levels. Subjects without the metabolic syndrome showed higher adiponectin (17.03 mu g/ml versus 13.85 mu g/ml, P < 0.001) and IL-10 (4.74 pg/ml versus 4.34 pg/ml, P = 0.014) levels, and lower serum hsCRP (0.38 mu g/ml versus 0.66 mu g/ ml, P = 0.001) and IL-6 (0.94 pg/ml versus 1.32 pg/ml, P = 0.009) levels compared to those with the metabolic syndrome. In multiple logistic regression analysis, the metabolic syndrome was associated with sex, age, waist circumference, systolic blood pressure, HDL cholesterol, triglyceride, fasting blood glucose and interleukin-10. Furthermore, serum adiponectin levels are associated with serum hsCRP, IL-6 and IL-10 levels. These results suggest that adiponectin might be associated with the metabolic syndrome through regulation of pro-/anti-inflammatory cytokines. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:235 / 240
页数:6
相关论文
共 30 条
  • [1] Bastard JP, 1999, CIRCULATION, V99, P2221
  • [2] INTERLEUKIN-10 IS A CENTRAL REGULATOR OF THE RESPONSE TO LPS IN MURINE MODELS OF ENDOTOXIC-SHOCK AND THE SHWARTZMAN REACTION BUT NOT ENDOTOXIN TOLERANCE
    BERG, DJ
    KUHN, R
    RAJEWSKY, K
    MULLER, W
    MENON, S
    DAVIDSON, N
    GRUNIG, G
    RENNICK, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) : 2339 - 2347
  • [3] Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans
    Choi, KM
    Lee, J
    Lee, KW
    Seo, JA
    Oh, JH
    Kim, SG
    Kim, NH
    Choi, DS
    Baik, SH
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 61 (01) : 75 - 80
  • [4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [5] Metabolic syndrome X: An inflammatory condition?
    Das, UN
    [J]. CURRENT HYPERTENSION REPORTS, 2004, 6 (01) : 66 - 73
  • [6] Association of low interleukin-10 levels with the metabolic syndrome in obese women
    Esposito, K
    Pontillo, A
    Giugliano, F
    Giugliano, G
    Marfella, R
    Nicoletti, G
    Giugliano, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (03) : 1055 - 1058
  • [7] Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS)
    Festa, A
    D'Agostino, R
    Howard, G
    Mykkänen, L
    Tracy, RP
    Haffner, SM
    [J]. CIRCULATION, 2000, 102 (01) : 42 - 47
  • [8] Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
    Fried, SK
    Bunkin, DA
    Greenberg, AS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 847 - 850
  • [9] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [10] Association between C-reactive protein and features of the metabolic syndrome -: A population-based study
    Fröhlich, M
    Imhof, A
    Berg, G
    Hutchinson, WL
    Pepys, MB
    Boeing, H
    Muche, R
    Brenner, H
    Koenig, W
    [J]. DIABETES CARE, 2000, 23 (12) : 1835 - 1839